COVID Tools/Resources:

Public Health:

Social Services

Crisis Lines/Mental Health Services 

  • Senior Safety Line
    • 1-866-299-1011
    • assists abused and at risk seniors
  • Connex Ontario Mental Health Helpline
    • 1-866-531-2600
    • online mental health supports
  • Bounce Back Ontario
    • assistance for adults and youth 15+ to manage symptoms of anxiety and depression; offers telephone coaching sessions
    • 1-866-345-0224
  • Mood Disorders Association of Ontario
    • 416-486-8046/1-888-486-8236
    • Telephone Support Line-1-866-363-MOOD
  • Anxiety Disorders Association– 1-888-223-2252
  • Drug and Alcohol Helpline
    • 1-800-565-8603
    • confidential information about drug and alcohol addiction and treatment programs
  • Detox and Withdrawal Central Access
    • 866-366-9513
    • information and referral to a detox or withdrawal management program
  • Mental Health Helpline
    • 1-866-531-2600
    • information and referrals on mental health services and supports
    • interpreters available

Mental Health

Mindfulness Resources  

  • Mindful Magazine
    • Currently offering free guided meditations
  • Meditation Oasis
    • There are many free guided meditation tracks that you can stream online, as well as some tracks and apps that are for sale.
  • Calm
    • Soothing and relaxing images and sounds
    • Has both free guided meditations and paid subscription options
    • Has app versions as well

Vitamin D and Covid-19

Palliative Care and COVID-19

  • COVID-19 Response – Free, online Palliative Care Modules
  • Basic pall care training for all medical and nursing students Free online training courses from reputable organizations like Pallium Canada (national, non-profit organization focused on building professional and community capacity to help improve the quality and accessibility of palliative care in Canada.)
  • National Institute for Health and Care Excellence (NICE)
  • COVID-19 rapid guideline: managing symptoms (including at the end of life) in the community (2020)
  • COVID-19 Symptoms Management
  • National Institute for Health and Care Excellence (NICE) in collaboration with NHS England and NHS Improvement. (2020). Managing COVID-19 symptoms (including at the end of life) in the community: summary of NICE guidelines

Oncology Guidelines for Covid-19 and Palliative Care

  • Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020;25(6):e936-e945. doi:10.1634/theoncologist.2020-0213 

Respiratory Health and COVID-19

  • Canadian Thoracic Society: COVID-19: Information for Healthcare Professionals & the Respiratory Community, CTS Guidance Documents
  • American Thoracic Society (ATS): ATS COVID-19 Resources
  • The ATS COVID-19 Resource Center provides free information to help healthcare providers, patients and their families manage a host of issues related to the COVID-19 pandemic

Ophthalmological Findings in Covid-19

  • Dockery DM, Rowe SG, Murphy MA, Krzystolik MG. The Ocular Manifestations and Transmission of COVID-19: Recommendations for Prevention [published online ahead of print, 2020 May 8]. J Emerg Med. 2020;S0736-4679(20)30398-X. doi:10.1016/j.jemermed.2020.04.060
  • Raony Í, Saggioro de Figueiredo C. Retinal outcomes of COVID-19: Possible role of CD147 and cytokine storm in infected patients with diabetes mellitus. Diabetes Res Clin Pract. 2020;165:108280. doi:10.1016/j.diabres.2020.108280

Post-COVID-19 Rehabilitation

Exercises in the Community and COVID-19

  • Exercising in times of COVID-19: What do experts recommend doing within four walls? Rodríguez, M. Á, Crespo, I., & Olmedillas, H. (2020). Revista Española De Cardiología (English Edition),73(7), 527-529. doi:10.1016/j.rec.2020.04.001
  • Wearing of cloth or disposable surgical face masks has no effect on vigorous exercise performance in healthy individuals. Shaw, K., Butcher S., KoJ., Zello, G.A., Chilibeck, P.D. (2020). Intl J Environ Res Public Health, 17, 8110; doi: 10.3390/ijerph17218110

Impacts of Anti-Asian Racism During Covid-19

  • Potential Impact of COVID-19-Related Racial Discrimination on the Health of Asian Americans. Chen JA, Zhang E, Liu CH. Am J Public Health. 2020 Sep 17:e1-e4. doi: 10.2105/AJPH.2020.305858. Online ahead of print. PMID: 32941063
  • Tessler H, Choi M, Kao G. The Anxiety of Being Asian American: Hate Crimes and Negative Biases During the COVID-19 Pandemic. Am J Crim Justice. 2020 Jun 10:1-11. doi: 10.1007/s12103-020-09541-5. Epub ahead of print. PMID: 32837158; PMCID: PMC7286555.
  • Psychological impact of anti-Asian stigma due to the COVID-19 pandemic: A call for research, practice, and policy responses. Misra S, Le PD, Goldmann E, Yang LH. Psychol Trauma. 2020 Jul;12(5):461-464. doi: 10.1037/tra0000821. Epub 2020 Jun 11. PMID: 32525390

Long-Term Effects of Covid-19 (Long Covid-19)

  • Management of post-acute covid-19 in primary care. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. BMJ. 2020 Aug 11;370:m3026. doi: 10.1136/bmj.m3026. PMID: 32784198.
  • Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network – United States. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, Gibbs KW, Erickson HL, Steingrub JS, Smithline HA, Gong MN, Aboodi MS, Exline MC, Henning DJ, Wilson JG, Khan A, Qadir N, Brown SM, Peltan ID, Rice TW, Hager DN, Ginde AA, Stubblefield WB, Patel MM, Self WH, Feldstein LR; IVY Network Investigators; CDC COVID-19 Response Team; IVY Network Investigators. March-June 2020. MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30):993-998. doi: 10.15585/mmwr.mm6930e1. PMID: 32730238; PMCID: PMC7392393.
  • Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Alzheimers Res Ther. 2020 Jun 4;12(1):69. doi: 10.1186/s13195-020-00640-3. PMID: 32498691; PMCID: PMC7271826.

Management During Pregnancy

  • SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes. Khalil A, Kalafat E, Benlioglu C, O’Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Heath P, Ladhani S, von Dadelszen P, Magee LA. EClinicalMedicine. 2020 Aug;25:100446. doi: 10.1016/j.eclinm.2020.100446. Epub 2020 Jul 3. PMID: 32838230; PMCID: PMC7334039.
  • COVID-19 during pregnancy: an overview of maternal characteristics, clinical symptoms, maternal and neonatal outcomes of 10,996 cases described in 15 countries. Figueiro-Filho EA, Yudin M, Farine D. J Perinat Med. 2020 Oct 1:/j/jpme.ahead-of-print/jpm-2020-0364/jpm-2020-0364.xml. doi: 10.1515/jpm-2020-0364. Epub ahead of print. PMID: 33001856.
  • Characteristics of Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, Nahabedian J, Anderson K, Gilboa SM. United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep. 2020 Jun 26;69(25):769-775. doi: 10.15585/mmwr.mm6925a1. PMID: 32584795; PMCID: PMC7316319.

Autoimmune Diseases and Covid-19

  • Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Kastritis E, Kitas GD, Vassilopoulos D, Giannopoulos G, Dimopoulos MA, Sfikakis PP. Rheumatol Int. 2020 Sep;40(9):1353-1360. doi: 10.1007/s00296-020-04629-x. Epub 2020 Jul 11. PMID: 32654078
  • Covid-19 and Autoimmune Diseases: A Systematic Review of Reported Cases. Saad MA, Alfishawy M, Nassar M, Mohamed M, Esene IN, Elbendary A. Curr Rheumatol Rev. 2020 Oct 29. doi: 10.2174/1573397116666201029155856. Online ahead of print. PMID: 33121413

Return to Sports following Covid-19

  • Graduated return to play guidance following COVID-19 infection. Elliott N, Martin R, Heron N, Elliott J, Grimstead D, Biswas A. Infographic. Br J Sports Med. 2020 Oct;54(19):1174-1175. doi: 10.1136/bjsports-2020-102637. Epub 2020 Jun 22. PMID: 32571796; PMCID: PMC7371566.
  • Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians. Wilson MG, Hull JH, Rogers J, Pollock N, Dodd M, Haines J, Harris S, Loosemore M, Malhotra A, Pieles G, Shah A, Taylor L, Vyas A, Haddad FS, Sharma S. Br J Sports Med. 2020 Oct;54(19):1157-1161. doi: 10.1136/bjsports-2020-102710. Epub 2020 Sep 2. PMID: 32878870; PMCID: PMC7513247.

Covid-19 in Children

  • Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York. Zachariah P, Johnson CL, Halabi KC, Ahn D, Sen AI, Fischer A, Banker SL, Giordano M, Manice CS, Diamond R, Sewell TB, Schweickert AJ, Babineau JR, Carter RC, Fenster DB, Orange JS, McCann TA, Kernie SG, Saiman L; Columbia Pediatric COVID-19 Management Group. JAMA Pediatr. 2020 Oct 1;174(10):e202430. doi: 10.1001/jamapediatrics.2020.2430. Epub 2020 Oct 5. PMID: 32492092; PMCID: PMC7270880.
  • International COVID-19 PICU Collaborative. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. Shekerdemian LS, Mahmood NR, Wolfe KK, Riggs BJ, Ross CE, McKiernan CA, Heidemann SM, Kleinman LC, Sen AI, Hall MW, Priestley MA, McGuire JK, Boukas K, Sharron MP, Burns JP; JAMA Pediatr. 2020 Sep 1;174(9):868-873. doi: 10.1001/jamapediatrics.2020.1948. PMID: 32392288; PMCID: PMC7489842.
  • Synthesis and systematic review of reported neonatal SARS-CoV-2 infections. Raschetti R, Vivanti AJ, Vauloup-Fellous C, Loi B, Benachi A, De Luca D. Nat Commun. 2020 Oct 15;11(1):5164. doi: 10.1038/s41467-020-18982-9. PMID: 33060565; PMCID: PMC7566441.

Drug Management

Strategies for managing dyspnea in the community

  • The Breathing, Thinking, Functioning clinical model: a proposal to facilitate evidence-based breathlessness management in chronic respiratory disease. Spathis A, Booth S, Moffat C, Hurst R, Ryan R, Chin C, Burkin J. NPJ Prim Care Respir Med. 2017 Apr 21;27(1):27. doi: 10.1038/s41533-017-0024-z. PMID: 28432286; PMCID: PMC5435098.

Cannabis Use and Covid-19

  • Stress, Emotional Intelligence and the Intention to Use Cannabis in Spanish Adolescents: Influence of COVID-19 Confinement. Liébana-Presa C, et al. Front Psychol. 2020. PMID: 33362646
  • Cannabis Use During the COVID-19 Pandemic in Canada: A Repeated Cross-sectional Study. Imtiaz S, Wells S, Rehm J, Hamilton HA, Nigatu YT, Wickens CM, Jankowicz D, Elton-Marshall T. J Addict Med. 2020 Dec 14. doi: 10.1097/ADM.0000000000000798. Online ahead of print. PMID: 33323693
  • Medication and substance use increases among people using cannabis medically during the COVID-19 pandemic. Boehnke KF, McAfee J, Ackerman JM, Kruger DJ. Int J Drug Policy. 2020 Nov 24:103053. doi: 10.1016/j.drugpo.2020.103053. Online ahead of print. PMID: 33250438
  • Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic. Bartel SJ, Sherry SB, Stewart SH. Subst Abus. 2020;41(4):409-412. doi: 10.1080/08897077.2020.1823550. Epub 2020 Oct 12. PMID: 33044893

Vaccine Guidance for Pregnant Individuals

COVID-19 Vaccines